Brief: Neuronos gets $2 mln funding for development of autism therapy
24/03/2025 20:33
March 24 (Reuters) - Beyond Air Inc XAIR.O: NEURONOS SECURES $2.0 MILLION IN FUNDING TO ADVANCE DEVELOPMENT OF AN INNOVATIVE AUTISM THERAPY Source text: ID:nGNX1pyYxw Further company coverage: XAIR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM